Skip to Main Content

Paper Details

Defining oligometastatic hormone sensitive prostate cancer and clinically significant outcomes: Implications on clinical trials?
Urol Oncol
1
2021
Author NameAffiliation
Katherine LajkoszUniversity of Toronto and University Health Network
Neil E FleshnerUniversity of Toronto and University Health Network
  • 1 - 2

Datasets

Release 1.2